Clinical trials
Phase 1/2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 3 |
| Completed | 2 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Children's Oncology Group | 1 |
| Institut Paoli-Calmettes | 1 |
| Kartos Therapeutics, Inc. | 1 |
| Poitiers University Hospital | 1 |
| Sun Pharma Advanced Research Company Limited | 1 |
| Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 9 |
| Leukemia, Myeloid, Chronic-Phase | 2 |
| Blast Crisis | 1 |
| Hypereosinophilic Syndrome | 1 |
| Leukemia, Myeloid, Accelerated Phase | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Mastocytosis, Systemic | 1 |
| Myelodysplastic Syndromes | 1 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.